In pancreas and breast cancer cell lines, mutant p53 can inhibit autophagy by the downregulation of BECN1, DRAM1, ATG12, SESN1/2, and P-AMPK and induce the activation of mTOR signaling promoting survival and cell proliferation [184]. This evidence concerns the gene TP53 and breast carcinoma.